Literature DB >> 26085525

Safe sedation in modern cardiological practice.

Stephen S Furniss1, J Robert Sneyd2.   

Abstract

Safe sedation is fundamental to many modern cardiological procedures, and following the publication of the report on safe sedation by the Academy of Medical Royal Colleges, this report discusses sedation specifically in cardiological practice. The major areas within cardiology that use sedation are cardioversion, catheter ablation particularly of atrial fibrillation, transoesophageal echocardiography, implantable device (cardiovascular implantable electronic device) procedures and other procedures such as transcatheter aortic valve replacement. There is increasing demand for cardiological sedation but there is wide geographical variation in its use and there are also growing data to support non-anaesthetists giving sedation. The use of benzodiazepines, particularly for short procedures, is common, but even here good record-keeping and audit together with an understanding of the continuum of sedation and having appropriately trained staff and the necessary facilities are vital. Nurse administration of propofol may be appropriate for some procedures in cardiology that require at least moderate sedation. Appropriate training is essential and the use of capnography and target controlled infusion pumps for propofol administration is recommended. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085525     DOI: 10.1136/heartjnl-2015-307656

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

Review 1.  Advances in management of electrophysiology and atrial fibrillation in the cardiac catheter laboratory: implications for anaesthesia.

Authors:  N Dooley; M Lowe; E M C Ashley
Journal:  BJA Educ       Date:  2018-10-01

2.  Deep sedation with propofol in patients undergoing left atrial ablation procedures-Is it safe?

Authors:  Leonie Foerschner; Nada Harfoush; Mara Thoma; Lovis Spitzbauer; Miruna Popa; Felix Bourier; Tilko Reents; Verena Kantenwein; Martha Telishevska; Katharina Wimbauer; Carsten Lennerz; Elena Risse; Amir Brkic; Susanne Maurer; Patrick Blazek; Fabian Bahlke; Christian Grebmer; Christof Kolb; Isabel Deisenhofer; Gabriele Hessling; Marc Kottmaier
Journal:  Heart Rhythm O2       Date:  2022-02-22

3.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

Review 4.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

5.  Vernakalant and electrical cardioversion for AF - Safe and effective.

Authors:  Alexander Simon; Jan Niederdoeckl; Karin Janata; Alexander Oskar Spiel; Nikola Schuetz; Sebastian Schnaubelt; Harald Herkner; Filippo Cacioppo; Anton Norbert Laggner; Hans Domanovits
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-11

6.  Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure.

Authors:  Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

Review 7.  Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation.

Authors:  Ratko Lasica; Lazar Djukanovic; Dejana Popovic; Lidija Savic; Igor Mrdovic; Nebojsa Radovanovic; Mina Radosavljevic Radovanovic; Marija Polovina; Radan Stojanovic; Dragan Matic; Ana Uscumlic; Milika Asanin
Journal:  Medicina (Kaunas)       Date:  2022-02-23       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.